secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNS Pharmaceuticals, Inc. (CNSP)
CIK:        0001729427
Form:       8-K
Filed at:   2025-03-20T23:59:59+00:00
Accession:  0001683168-25-001754
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CNS Pharmaceuticals ups ATM sales capacity to $43.5M from $30.2M; $23.75M raised so far
--------------------------------------------------------------------------------

- Company increased aggregate sales price under A.G.P. Sales Agreement to $43.5M on March 20, 2025.
- Prior limit was $30.2M; remaining capacity before increase was $6.45M, now total unissued capacity ~$19.75M.
- As of March 20, 2025, 2,522,755 shares sold for gross proceeds of ~$23.75M; 2,944,381 shares outstanding.
- Shares sold under shelf registration S-3 (File 333-279285) that became effective May 17, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729427/000168316825001754/0001683168-25-001754-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729427/000168316825001754/cns_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-001754

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer